Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Native Coronary Artery Instead of SAphenous Vein Graft Intervention for Treatment of Significant Saphenous Vein Graft Lesions

NCT05187351 is registered in ClinicalTrials.gov with Minneapolis Heart Institute Foundation as lead sponsor.

NCT NCT05187351
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05187351 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Native Coronary Artery Instead of SAphenous Vein Graft Intervention for Treatment of Significant Saphenous Vein Graft Lesions
Lead sponsor
Minneapolis Heart Institute Foundation
Phase
Observational
Overall status
Active, not recruiting
Start date
November 21, 2021
Completion date
January 31, 2030
Enrollment
99 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

percutaneous coronary intervention, target vessel failure in saphenous vein grafts